Article Details
Retrieved on: 2025-03-21 04:52:06
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Wedbush initiates coverage on Zenas BioPharma, citing strong potential for obexelimab in autoimmune diseases, with key clinical data expected in ...
Article found on: www.benzinga.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here